论文部分内容阅读
目的:分析我院门诊癌痛患者麻醉药品使用情况,为临床中合理的用药提供参考依据。方法:统计分析2014年6月至2015年2月期间我院236例门诊癌痛患者麻醉药使用天数、限日剂量(DDD)、用药频度(DDDS)、日均费用(DDC)以及药物利用指数(DUI)。结果:门诊癌痛患者麻醉药品的使用差异较大,男性多于女性,老年患者高于其他年龄段患者,用药频度居前3为的为吗啡缓释片、吗啡注射液、羟考酮缓释片;日均费用最高的为羟考酮缓释片,其次为吗啡缓释片、吗啡注射液;药物利用率大于1的有吗啡缓释片、吗啡注射液、盐酸布桂嗪注射液、盐酸哌替啶注射液。结论:我院门诊癌痛患者麻醉用药符合临床指导原则,但是在实际的应用过程中,我们还需要不断的改善和提高。
Objective: To analyze the use of narcotic drugs in outpatients with cancer pain and to provide a reference for rational use of drugs in clinical practice. Methods: A total of 236 outpatients with cancer pain in our hospital from June 2014 to February 2015 were statistically analyzed for days of use, DDD, DDDS, DDC, and drug use Index (DUI). Results: The use of narcotic drugs in outpatients with cancer pain was quite different. There were more males than females and the elderly patients were higher than those in other age groups. The top three drug users were morphine sustained release tablets, morphine injection and oxycodone Release tablets; daily average cost of oxycodone sustained-release tablets, followed by morphine sustained-release tablets, morphine injection; drug utilization rate greater than 1 with morphine sustained-release tablets, morphine injection, bucuremine hydrochloride injection, Pethidine hydrochloride injection. CONCLUSION: The anesthesia medication for outpatients with cancer pain in line with clinical guidelines, but in the actual application process, we also need continuous improvement and improvement.